Deborah Franke Speranzo Email and Phone Number
Deborah Franke Speranzo work email
- Valid
- Valid
- Valid
- Valid
Deborah Franke Speranzo personal email
Deborah Franke Speranzo phone numbers
Experienced Executive Sales Director commercial strategic leader with demonstrated history of successful product launches in rare disease, AAV gene therapy, neuromuscular, SMA, neurology, oncology, dermatology and hematology. Experience leading strategy and execution of elite field collaboration teams including sales, reimbursement, channel and advocacy teams calling on both pediatric and adult hospitals as well as community accounts. Skilled in complex multi-million dollar gene therapy models requiring partnership across all facets of healthcare system including hospital P&T, EMR, SOPs, procurement, administration, infusion site readiness and integration. Highly adept at building launch teams that excell at pre and post launch execution, building/acheiving KPI metrics, strategic account development, reimbursement, buy and bill, market access and community advocacy. Graduated from The University of Texas at Austin.
Sobi - North America
View-
Commercial Business Director - Health SystemsSobi - North America Nov 2024 - PresentWithin the therapeutic area haematology, immunology and specialty care, Sobi is dedicated to the treatment of rare, ultra-rare and severe diseases. This dedication combined with a rare expertise has resulted in a long history of developing transformative treatments for patients with high unmet medical needs. Our ability to identify unmet medical needs, develop treatments and secure evidence has been instrumental in the success of our current therapies. We keep challenging the status quo and are dedicated to the continuous discovery of high-potential therapies that we can develop to make a lasting impact and create sustainable value, sooner rather than later. Through close collaboration with rare disease communities, we continue to improve access to care for those otherwise overlooked.
-
Director, Gene TherapyBiomarin Pharmaceutical Inc. Jul 2023 - Nov 2024San Rafael, Ca, UsAt BioMarin, through our unparalleled expertise in genetics and molecular biology, we will continue to develop targeted therapies that address the root cause of the conditions we seek to treat. Applying our knowledge to make a transformative impact is not just a calling, but an obligation to those who will benefit most. Transforming lives through genetic discovery. -
Director, Rare Disease HematologyAgios Pharmaceuticals Apr 2021 - Jul 2023Cambridge, Ma, UsWhere science meets heart. Passionately committed to transforming the lives of people with genetically defined rare diseases including Pyruvate Kinase Deficiency (PKD), Thalassemias and Sickle-Cell Disease. -
Director - Aav Gene Therapy, Sma (Formerly Avexis)Novartis Gene Therapies 2020 - Apr 2021Basel, Baselstadt, ChAveXis is now Novartis Gene Therapies. Novartis Gene Therapies is dedicated to developing and commercializing gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. (SMA, Spinal Muscle Atrophy, rare neurological disease, gene therapy, Zolgensma) -
Director - Aav Gene Therapy, SmaAvexis, Inc. 2018 - 2020At AveXis, we work relentlessly to bring gene therapy to patients and families affected by rare and life-threatening neurological genetic diseases, like spinal muscular atrophy (SMA), Rett syndrome (RTT), and a genetic form of amyotrophic lateral sclerosis (ALS). Our dedication to advancing gene-based medicine can make a difference in the fight against devastating hereditary diseases.
-
West Region General Manager - Hematology Rare Disease (Formerly Biogen)Bioverativ, A Sanofi Company 2017 - 2018Waltham, Ma, UsHemophilia, rare disease2014 President's Circle Winner2016 President's Circle WinnerBioverativ is dedicated to transforming the lives of people with hemophilia, cold agglutinin disease and other rare blood disorders. As an independent biopharmaceutical company spun out of Biogen’s hemophilia business, it brings a strong legacy of innovation, world-class science, and commitment to the rare blood disorders community. Bioverativ is united by a singular purpose: to create progress where patients need it most. -
West Region General Manager - Hemophilia Rare DiseaseBiogen 2012 - 2017Cambridge, Ma, UsHemophilia, rare disease2014 President's Circle Winner2016 President's Circle WinnerBiogen is a pioneer in neuroscience. Since its founding in 1978 as one of the world’s first global biotechnology companies, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological and hematologic diseases. -
National Sales Director - Oncology, Hepc, Rheumatology, Dermatology, Hiv, TransplantAvella Specialty Pharmacy 2010 - 2012Phoenix, Az, UsAvella is a national specialty pharmacy dedicated to empowering patients, providers and other organizations across the entire healthcare continuum. Invested in improving the health—and the lives—of the people they serve, Avella accomplishes this goal by acting as expert clinicians, passionate advocates, committed healthcare partners and strategic innovators. -
District Sales Manager - Oncology/HematologyAmgen 2008 - 2010Thousand Oaks, Ca, UsAmgen was incorporated on April 8, 1980, in Thousand Oaks, California, during the dawn of biotechnology. The company was created around a simple idea—that emerging research in biology could lead to meaningful advances if the right scientists could be assembled and given the appropriate resources. Since then, Amgen has grown to be one of the world's leading biotechnology companies, deeply rooted in science and innovation and focused on helping patients with serious illness. -
New Hire & Sr. Manager Training & Development - Inflammation (2 Roles)Amgen 2005 - 2008Thousand Oaks, Ca, UsStrategic Training Manager - Inflammation Business Unit
-
Dermatology & Rheumatology Specialty SalesAmgen 2001 - 2005Thousand Oaks, Ca, UsImmunex was acquired by Amgen in 2002
-
Territory Business ManagerBristol Myers Squibb Jan 1999 - Dec 2001Lawrence Township, Nj, UsBristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.Deborah's areas of focus at BMS was Cardiology, Endocrinology, Neurology, Internal Medicine & Primary Care Sales.
Deborah Franke Speranzo Skills
Deborah Franke Speranzo Education Details
-
The University Of Texas At Austin
Frequently Asked Questions about Deborah Franke Speranzo
What company does Deborah Franke Speranzo work for?
Deborah Franke Speranzo works for Sobi - North America
What is Deborah Franke Speranzo's role at the current company?
Deborah Franke Speranzo's current role is Gene Therapy | Rare Disease | Biotech | Commercial Director | Pre-Approval & Post-Launch Strategy |.
What is Deborah Franke Speranzo's email address?
Deborah Franke Speranzo's email address is de****@****ios.com
What is Deborah Franke Speranzo's direct phone number?
Deborah Franke Speranzo's direct phone number is +160299*****
What schools did Deborah Franke Speranzo attend?
Deborah Franke Speranzo attended The University Of Texas At Austin.
What skills is Deborah Franke Speranzo known for?
Deborah Franke Speranzo has skills like Rheumatology, Oncology, Dermatology, Pharmaceutical Industry, Neurology, Cardiology, Pharmaceutical Sales, Hematology, Product Launch, Sales Operations, Sales Management, Biotechnology.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial